Reciprocal interference of maternal and infant immunization in protection against pertussis (Q40830016)

24 September 2017

title

Reciprocal interference of maternal and infant immunization in protection against pertussis (English)

1 reference

24 September 2017

0 references

Nathalie Mielcarek

2

0 references

Camille Locht

object named as

Camille Locht

series ordinal

3

0 references

author name string

Pascal Feunou Feunou

series ordinal

1

1 reference

24 September 2017

language of work or name

English

0 references

publication date

14 January 2016

1 reference

24 September 2017

1 reference

24 September 2017

volume

34

1 reference

24 September 2017

issue

8

1 reference

24 September 2017

page(s)

1062-1069

1 reference

Epidemic pertussis in 2012--the resurgence of a vaccine-preventable disease

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.01.011

Pertussis hospitalizations among infants in the United States, 1993 to 2004.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.01.011

Pathology and pathogenesis of fatal Bordetella pertussis infection in infants.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.01.011

Effectiveness of acellular pertussis vaccine assessed by hospital-based active surveillance in Germany

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.01.011

Effectiveness of maternal pertussis vaccination in England: an observational study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.01.011

Safety and immunogenicity of tetanus diphtheria and acellular pertussis (Tdap) immunization during pregnancy in mothers and infants: a randomized clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.01.011

Immune responses in infants whose mothers received Tdap vaccine during pregnancy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.01.011

Live attenuated B. pertussis as a single-dose nasal vaccine against whooping cough

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.01.011

Genetic stability of the live attenuated Bordetella pertussis vaccine candidate BPZE1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.01.011

Long-term immunity against pertussis induced by a single nasal administration of live attenuated B. pertussis BPZE1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.01.011

Intranasal murine model of Bordetella pertussis infection. I. Prediction of protection in human infants by acellular vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.01.011

T- and B-cell-mediated protection induced by novel, live attenuated pertussis vaccine in mice. Cross protection against parapertussis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.01.011

A phase I clinical study of a live attenuated Bordetella pertussis vaccine--BPZE1; a single centre, double-blind, placebo-controlled, dose-escalating study of BPZE1 given intranasally to healthy adult male volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.01.011

Neonatal pertussis, cocooning and maternal immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.01.011

Effectiveness of maternal influenza immunization in mothers and infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.01.011

Adverse event reports after tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccines in pregnant women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.01.011

Safety of pertussis vaccination in pregnant women in UK: observational study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.01.011

Importance of timing of maternal combined tetanus, diphtheria, and acellular pertussis (Tdap) immunization and protection of young infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.01.011

Maternal immunization with tetanus-diphtheria-pertussis vaccine: effect on maternal and neonatal serum antibody levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.01.011

The effects of active immunization of the mother upon the offspring

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.01.011

The protective role of maternally derived antibodies against Bordetella pertussis in young infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.01.011

Pertussis serostatus among neonates born to Hispanic women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.01.011

Transplacental and Transcolostral Immunity to Pertussis in a Mouse Model Using Acellular Pertussis Vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.01.011

Maternal immunity provides protection against pertussis in newborn piglets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.01.011

The O antigen enables Bordetella parapertussis to avoid Bordetella pertussis-induced immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.01.011

Heparin-inhibitable lectin activity of the filamentous hemagglutinin adhesin of Bordetella pertussis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.01.011

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2016.01.011

1 reference

24 September 2017

1 reference